Read the screenplay: FANNIEGATE — $7 trillion. 17 years. The biggest fraud in American capital markets.
|glenbradford-wordpressChina|1 min read

Bottoms up, bottoms up $SKBI $LTUS $CNAM $CCME $UTA $LPH $CHBT - just to name a few

Bottoms: SKBI - $6 http://investorshub.advfn.com/boards/read_msg.aspx?message_id=54530254 SKBI...NICE growth/profit machine...Here's the kicker...

SKBI's new vaccine production plant will add $12M - $14M to the top line next year @ 70% margin. Recent Hubei acquisition will add approx $4-$6M to the top line next year at approx 40% margin. That's approx $10M EXTRA in gross profit next year not counting organic growth or anything else. That's more than Skystar has in gross profit for the first 6 months of this year ($7M) and first 6 month EPS is $0.49.

HUGE Q3 coming up also. SKBI could easily come in w/ $1.80 - $2 EPS for FY2010 and $3++ for FY2011 (based on approx 7.1M shares outstanding). Also, Skystar mentioned that they have enough cash on hand to complete the Jiangsu based micro-organism facility which they already have a deposit on. Micro-organisms = approx 70% profit margin. (The Jiangsu acquisition is projected to be completed in the third quarter of 2010, so we'll see what happens. That's only a couple of weeks away.)

SKBI's Rodman & Renshaw presentation is well worth a listen IMO.

Next year's estimated growth is mind boggling, especially when adding in organic growth and the Jiangsu based micro-organism facility if and when the acquisition is complete.

Current share price = $6.50.

CNAM - China Armco $3 CCME - China MediaExpress Holdings Inc (Public, NASDAQ:CCME - $7 UTA - Universal Travel Group (Public, NYSE:UTA) - $4 LPH - Longwei Petroleum - $2 CHBT - China Biotics $9 LTUS - Lotus Pharmaceuticals $1

lots of bottoming happening in this space.

Found this useful? Share it.

Act As If

Question Everything, Set Life Goals, Achieve. — Free PDF download or grab it on Amazon.

Enjoyed this? Get more like it.

Glen's Musings — AI, investing, and building things. Occasional. Free.

Related Posts

Keep Exploring

Disclaimer: This blog post reflects the author's personal opinions at the time of writing and is not financial, investment, or legal advice. Glen Bradford holds positions in securities discussed on this site. Past performance is not indicative of future results. Do your own research and consult qualified professionals before making investment decisions. Some content on this site was generated or edited with AI assistance.